This inventor holds 1 USPTO granted patent. Top assignee: University of Alberta. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Kamaljit Kaur and Alzheimer’s Disease Research
Introduction
Kamaljit Kaur is an inventor associated with Edmonton, Canada, and the University of Alberta. Her patent work concerns potential approaches to treating Alzheimer’s disease.
Latest Patents
Kaur is credited with 1 patent, titled “Brain Penetrant Amylin Receptor Based Peptides for Alzheimer’s Disease.” The patent describes amylin receptor antagonists designed to bind to the receptor and inhibit the activity of amylin or amyloid-beta protein. It also covers pharmaceutical compositions and methods for preparing and using these antagonists to treat, prevent, or ameliorate Alzheimer’s disease.
Career Highlights
Kaur’s listed invention reflects research into the relationship between amylin receptors and Alzheimer’s disease. The patent describes possible therapeutic applications, rather than establishing that the proposed treatments are clinically effective.
Collaborations
Kaur’s listed coworkers include Jack Jhamandas and Rania Soudy. Her work is associated with the University of Alberta.
Conclusion
Kamaljit Kaur’s patent focuses on amylin receptor antagonists as a potential avenue for Alzheimer’s disease research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
